Global Urinary Tract Infections Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2017-2023
Global
Urinary Tract Infections Market: Information By Drug Class (Quinolones
(Ciprofloxacin, Enoxacin, Norfloxacin, Ofloxacin, Pefloxacin, Fleroxacin),
Β-Lactam &Cephalosporins (Amoxicillin-Clavulanate, Cefdinir, Cefaclor,
Cefpodoxime-Proxetil), Aminoglycosides, Penicillin, Azoles), Application
(Urethritis, Cystitis, Pyelonephritis), Pathogen (Escherichia coli,
Staphylococcus saprophyticus, Klebsiellapneumoniae, Proteus mirabilis,
Enterococcus faecalis), End-User (Hospitals, Clinics, Self-Administered) and
Region (Americas, Europe, Asia-Pacific, Rest of the World) - Forecast till 2027
Urinary Tract Infections Market Highlights
The global urinary
tract infection market is poised to surpass USD 9.89 billion at a
significant 3.6% CAGR over the estimated years (2017-2023). UTI or urinary
tract infection is an infection occurring in the upper or lower urinary tract
including the urethra and the bladder. UTIs are of two types- urethritis and
cystitis. The former is an infection that is takes place in the urethra while
the latter is an infection that takes place in the bladder. Getting this
infection is easy. Bacteria that lives in the genital, vagina and anal areas
can enter the urethra and travel the bladder thereby causing infection. The
common symptoms related to UTI include burning and painful sensation while
urinating and frequent, strong urge to urinate. The primary causes of urinary
tract infection include obesity, diabetes, bowel incontinence, poor personal
hygiene, sexual intercourse, enlarged prostate gland and blockage in the
urinary tract mainly kidney stone.
There are abundant factors that
is propelling the growth of the urinary tract infection market. These factors as
per the MRFR (Market Research Future) report include increase in hospital-borne
infections, rising geriatric population, emergence of drug-resistant bacteria,
rising health awareness amid women, increase in diagnosis, prevalence rate of
diseases mainly kidney stone and diabetes, increasing incidences of UTI,
changing lifestyle pattern, favorable reimbursement policies and higher
treatment compliance. On the contrary, increasing market fragmentation, loss of
patents, unmet clinical needs, growing drug resistance, lack of awareness amid
people, strict government regulations, adverse effects of medications, poor
patient compliance and generic erosion are factors that may restrict urinary
tract infection market growth.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6138
Urinary Tract Infection (UTI)
Market Segmentation
MRFR report offers a broad
segmental analysis of the urinary tract infection market on the basis of drug
class, clinical indications and end users.
Based on drug class, it is
segmented into azoles, β-lactam, aminoglycosides, quinolones and others.
Based on clinical indications,
the urinary tract infection market is segmented into pyelonephritis, cystitis,
urethritis and others.
Based on end users, it is
segmented into self-administered, hospitals and others.
Urinary Tract Infection (UTI)
Market Regional Analysis
By region, the urinary tract
infection market covers growth opportunities and latest trends across North
America, Europe, Asia Pacific, and Middle East and Africa. Of these, North
America will stay at the forefront in the urinary tract infection market over
the estimated years owing to increasing prevalence of diseases especially
diabetes, high diagnostic rate and increasing healthcare awareness. US is the
key contributor here. The current regulatory shift in the United States
including Hospital Readmissions Reduction Program coupled with Affordable Care
Act and also Medicare initiatives for penalizing unnecessary patient
readmissions is likely to drive the UTI market in the US. The urinary tract
infection market in Europe will have the second major share over the estimated
years due to increasing research and development and higher hospitalization
rate. In the APAC region, the urinary tract infection market is predicted to
grow at the fastest pace with India and China being the key contributors.
Factors that are resulting in the growth of the market in this region include
increased disposable income, growing healthcare infrastructures, gradual use of
improved technologies, increasing rate of diagnostics, growing personal care
& hygiene and growing awareness. Besides, rising geriatric population is
also a factor that is anticipated to increase the demand for UTI therapeutics
with the population being at the risk of developing the infection.
Urinary Tract Infection (UTI)
Market Key Players
Leading players profiled in the
urinary tract infection market include Johnson & Johnson, Cipla Inc.,
AstraZeneca, F. Hoffmann-La Roche Ltd, Pfizer Inc., Dr. Reddy’s Laboratories
Ltd, GlaxoSmithKline Novartis AG, Bayer AG and others.
April 2019- Professor Douglas
Kell along with his colleagues have come up with a new technology which can
help to identify the most powerful antibiotic for killing organisms in UTI.
This new technology will play a pivotal part in fighting anti-microbial
resistance. It uses flow cytometry that can detect and count individual
bacteria present in the urine sample as well as decide which antibiotic will be
the most efficient to kill those bacteria. The patient will then be prescribed
with an antibiotic that is the most effective.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/upcoming-reports/urinary-tract-infection-market-6138
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and intelligence
services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment